BCG vaccine elicits both T-cell mediated and humoral immune responses directed against mycobacterial lipid components
- 17 July 2006
- Vol. 24 (29-30) , 5700-5707
- https://doi.org/10.1016/j.vaccine.2006.04.049
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (16017298, 17047023)
- Takeda Science Foundation
- Japan Society for the Promotion of Science (15390317)
This publication has 43 references indexed in Scilit:
- Diacylated Sulfoglycolipids Are Novel Mycobacterial Antigens Stimulating CD1-restricted T Cells during Infection with Mycobacterium tuberculosis The Journal of Experimental Medicine, 2004
- Mycobacteria Target DC-SIGN to Suppress Dendritic Cell FunctionThe Journal of Experimental Medicine, 2002
- Processing of Mycobacterium tuberculosis Antigen 85B Involves Intraphagosomal Formation of Peptide–Major Histocompatibility Complex II Complexes and Is Inhibited by Live Bacilli that Decrease Phagosome MaturationThe Journal of Experimental Medicine, 2001
- Clinical Evaluation of Anti-Tuberculous Glycolipid Immunoglobulin G Antibody Assay for Rapid Serodiagnosis of Pulmonary TuberculosisJournal of Clinical Microbiology, 2001
- CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infectionNature, 2000
- CD1-Restricted T Cell Recognition of Microbial Lipoglycan AntigensScience, 1995
- Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPaseScience, 1994
- Structure and antigenicity of lipoarabinomannan from Mycobacterium bovis BCGJournal of General Microbiology, 1993
- Immunity to Intracellular BacteriaAnnual Review of Immunology, 1993
- CDlb restricts the response of human CD4−8−T lymphocytes to a microbial antigenNature, 1992